Immunizations

French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
June 16, 2020 - 8:11 am
LONDON (AP) — Scientists at Imperial College London will start immunizing people in Britain this week with their experimental coronavirus shot, while pharmaceutical company Sanofi and the French government announced more than 800 million euros ($890 million) in investment Tuesday as part of the...
Read More
A woman wearing a face mask walks near a banner showing precautions against the new coronavirus at an exhibition and convention center in Goyang, South Korea, Friday, June 12, 2020. (AP Photo/Lee Jin-man)
June 13, 2020 - 10:56 pm
BEIJING — China is reporting its highest daily total of coronavirus cases in two months after the capital’s biggest wholesale food market was shut down following a resurgence in local infections. Officials say there were 57 confirmed cases in the 24 hours through midnight Saturday. That was the...
Read More
FILE - In this Thursday, Feb. 20, 2020 file photo, a view of the AstraZeneca logo, on a building, in South San Francisco, Calif. Drug maker AstraZeneca secured its first agreements Thursday, May 21, 2020 for 400 million doses of a COVID-19 vaccine, bolstered by an investment from the U.S. vaccine agency. (AP Photo/Jeff Chiu, File)
June 13, 2020 - 10:20 am
LONDON (AP) — Pharma giant AstraZeneca struck a deal Saturday with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental COVID-19 vaccine, as efforts to boost manufacturing capacity continue at pace. The alliance, which was forged by Germany, France, Italy and...
Read More
Workers in protective suits carry the coffin of a suspected victim of COVID-19 during a burial at Pondok Ranggon cemetery in Jakarta, Indonesia, Friday, June 12, 2020. (AP Photo/Achmad Ibrahim)
June 12, 2020 - 8:16 am
NEW DELHI (AP) — India’s coronavirus caseload has become the fourth-largest in the world, overtaking Britain, by adding 10,956 new cases in yet another biggest single-day spike. India's two-month lockdown kept transmissions low but in a large population of 1.3 billion, people remain susceptible and...
Read More
FILE - In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The first experimental COVID-19 vaccine in the U.S. is on track to begin a huge study next month to prove if it really can fend off the coronavirus, its manufacturer announced Thursday, June 11 -- a long-awaited step in the global vaccine race. The vaccine, developed by the U.S. National Institutes of Health and Moderna Inc., will be tested in 30,000 volunteers -- some given the real shot and some a dummy shot. (AP Photo/Ted S. Warren, File)
June 11, 2020 - 2:16 pm
The first experimental COVID-19 vaccine in the U.S. is on track to begin a huge study next month to prove if it really can fend off the coronavirus, while hard-hit Brazil is testing a different shot from China. Where to do crucial, late-stage testing and how many volunteers are needed to roll up...
Read More
Newly dug, empty graves fill the Sao Luiz cemetery where COVID-19 victims will be buried in Sao Paulo, Brazil, Thursday, June 4, 2020. (AP Photo/Andre Penner)
June 04, 2020 - 10:47 pm
LONDON (AP) — A vaccine summit has raised billions of dollars to immunize children in developing countries as experts wrestled with how any potential vaccine against the coronavirus might be distributed globally — and fairly. The United Nations and the International Red Cross and Red Crescent...
Read More
Students wearing face masks to help protect against the spread of the new coronavirus stand in a line to have their body temperatures checked before entering their classrooms at a high school in Ulsan, South Korea, Wednesday, Jun 3, 2020. (Bae Byung-soo/Newsis via AP)
June 03, 2020 - 9:39 pm
The Latest on the coronavirus pandemic. COVID-19 causes mild or moderate symptoms for most people. For some, especially older adults and people with existing health problems, it can cause more severe illness or death. ___ SEOUL, South Korea __ South Korea has confirmed 39 additional cases of the...
Read More
In this April 2014 photo provided by the Vaccine and Infectious Disease Organization-International Vaccine Centre at the University of Saskatchewan, a researcher holds a ferret at their facility in Saskatoon, Saskatchewan, Canada. In 2020, the lab is working with 300 ferrets developing a COVID-19 coronavirus vaccine candidate and testing other vaccine candidates and therapeutics. (VIDO-InterVac at the University of Saskatchewan via AP)
June 02, 2020 - 5:29 am
The global race for a COVID-19 vaccine boils down to some critical questions: How much must the shots rev up someone’s immune system to really work? And could revving it the wrong way cause harm? Even as companies recruit tens of thousands of people for larger vaccine studies this summer, behind...
Read More
This May 4, 2020 photo from the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a poll conducted May 14-18 by The Associated Press-NORC Center for Public Affairs Research. (University of Maryland School of Medicine via AP)
May 27, 2020 - 1:38 am
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a new poll from The Associated Press-NORC Center for Public Affairs Research. That’s surprisingly low considering the effort going into the global race for a...
Read More
May 27, 2020 - 1:32 am
WASHINGTON, D.C. (AP) — AP-NORC poll: About half of Americans would get a COVID-19 vaccine if they could, while many are unsure or would refuse.
Read More

Pages